Global brokerage firm Jefferies upgraded Gland Pharma's stock to buy from underperform with an increased price target of Rs 1,640 from Rs 1,065 earlier....
JPMorgan maintained an overweight rating on Godrej Consumer but raised the target price to Rs 1135 from Rs 1075 earlier. The company reported robust...